Skip to content

A Retrospective Study of Endoscopic Ligation Combined with Sclerotherapy versus Milligan-Morgan Hemorrhoidectomy for the Treatment of Mixed Hemorrhoids

A Retrospective Study of Endoscopic Ligation Combined with Sclerotherapy versus Milligan-Morgan Hemorrhoidectomy for the Treatment of Mixed Hemorrhoids

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600119592
Enrollment
Unknown
Registered
2026-02-28
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mixed Hemorrhoids

Interventions

Case group:As a retrospective cohort study, this research involved no active intervention implemented by the research team.

Sponsors

The 923rd Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18–70 years. 2. The patients had good surgical tolerance, no definite contraindications, and had signed the informed consent documents related to the surgery. 3. All enrolled patients met the diagnostic criteria for grade ? or ? mixed hemorrhoids specified in the Chinese Guidelines for the Diagnosis and Treatment of Hemorrhoidal Disease (2020 Edition).

Exclusion criteria

Exclusion criteria: 1. Patients with grade ? mixed hemorrhoids or external hemorrhoids. 2. Patients complicated with other anorectal diseases such as anal fissure, anal fistula, and anal sinusitis. 3. Patients with severe cardiovascular and cerebrovascular diseases, inflammatory bowel disease, or gastrointestinal malignant tumors. 4. Patients complicated with severe hepatorenal dysfunction or coagulation disorders. 5. Patients with missing or incomplete medical records or follow-up data. 6. Female patients who are pregnant, lactating, or in the puerperium. 7. Patients with cognitive impairment, mental disorders, or other conditions that affect treatment compliance. 8. Patients with a history of hypersensitivity to sclerosing agents.

Design outcomes

Primary

MeasureTime frame
Hemorrhoid recurrence rate;patient satisfaction;

Secondary

MeasureTime frame
pain score;hematochezia score;mucosal prolapse score;anal pruritus score;perianal edema;urinary retention;defecation difficulty;anal distension and falling sensation;postoperative fever;

Countries

China

Contacts

Public ContactYan Geng

The 923rd Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army

drggyn@163.com+86 186 4894 5667

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026